טוען...

Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy

OBJECTIVE: To investigate the safety and efficacy of rituximab in multiple sclerosis (MS). METHODS: In this retrospective uncontrolled observational multicenter study, off-label rituximab-treated patients with MS were identified through the Swedish MS register. Outcome data were collected from the M...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Neurology
Main Authors: Salzer, Jonatan, Svenningsson, Rasmus, Alping, Peter, Novakova, Lenka, Björck, Anna, Fink, Katharina, Islam-Jakobsson, Protik, Malmeström, Clas, Axelsson, Markus, Vågberg, Mattias, Sundström, Peter, Lycke, Jan, Piehl, Fredrik, Svenningsson, Anders
פורמט: Artigo
שפה:Inglês
יצא לאור: Lippincott Williams & Wilkins 2016
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5109942/
https://ncbi.nlm.nih.gov/pubmed/27760868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003331
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!